<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Hexestrol</id>
	<title>Hexestrol - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Hexestrol"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Hexestrol&amp;action=history"/>
	<updated>2026-04-12T09:14:18Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Hexestrol&amp;diff=49882&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Hexestrol&amp;diff=49882&amp;oldid=prev"/>
		<updated>2025-03-18T10:32:07Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:32時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49881:rev-49882 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Hexestrol&amp;diff=49881&amp;oldid=prev</id>
		<title>bsd&gt;JWBE: removed Category:Phenols; added Category:4-Hydroxyphenyl compounds using HotCat</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Hexestrol&amp;diff=49881&amp;oldid=prev"/>
		<updated>2024-10-21T10:05:20Z</updated>

		<summary type="html">&lt;p&gt;removed &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Phenols&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Phenols (存在しないページ)&quot;&gt;Category:Phenols&lt;/a&gt;; added &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:4-Hydroxyphenyl_compounds&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:4-Hydroxyphenyl compounds (存在しないページ)&quot;&gt;Category:4-Hydroxyphenyl compounds&lt;/a&gt; using &lt;a href=&quot;/w/index.php?title=WP:HC&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HC (存在しないページ)&quot;&gt;HotCat&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields     = &lt;br /&gt;
| Watchedfields      = &lt;br /&gt;
| verifiedrevid      = &lt;br /&gt;
| IUPAC_name         = 4-[4-(4-Hydroxyphenyl)hexan-3-yl]phenol&lt;br /&gt;
| image              = Hexestrol.svg&lt;br /&gt;
| width              = 250px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;| tradename          = Synestrol, Synoestrol, Estrifar, Estronal&lt;br /&gt;
| pregnancy_AU       = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US       = &amp;lt;!-- A / B / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU           = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA           = &lt;br /&gt;
| legal_UK           = &lt;br /&gt;
| legal_US           = &lt;br /&gt;
| legal_status       = &lt;br /&gt;
| routes_of_administration = [[Oral administration|By mouth]], [[intramuscular injection]] (as an [[ester]])&lt;br /&gt;
| class              = [[Nonsteroidal estrogen]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;| bioavailability    = &lt;br /&gt;
| protein_bound      = &lt;br /&gt;
| metabolism         = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion          = &amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref     = &lt;br /&gt;
| CAS_number         = 84-16-2&lt;br /&gt;
| CAS_supplemental   = &lt;br /&gt;
| ATC_prefix         = &lt;br /&gt;
| ATC_suffix         = &lt;br /&gt;
| PubChem            = 3606&lt;br /&gt;
| IUPHAR_ligand      = 2823&lt;br /&gt;
| DrugBank_Ref       = &lt;br /&gt;
| DrugBank           = DB07931&lt;br /&gt;
| ChemSpiderID_Ref   = &lt;br /&gt;
| ChemSpiderID       = 3480&lt;br /&gt;
| UNII_Ref           = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII               = 10BI795R7D&lt;br /&gt;
| KEGG_Ref           = &lt;br /&gt;
| KEGG               = D01641&lt;br /&gt;
| ChEBI_Ref          = &lt;br /&gt;
| ChEBI              = 31669&lt;br /&gt;
| ChEMBL_Ref         = &lt;br /&gt;
| ChEMBL             = 6615&lt;br /&gt;
| synonyms           = Hexoestrol; Hexanestrol; Hexanoestrol; Dihydrodiethylstilbestrol; Dihydrostilbestrol; 4,4&amp;#039;-(1,2-Diethylethylene)diphenol; NSC-9894&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C                  = 18&lt;br /&gt;
| H                  = 22&lt;br /&gt;
| O                  = 2&lt;br /&gt;
| SMILES             = CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O&lt;br /&gt;
| StdInChI           = 1S/C18H22O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,17-20H,3-4H2,1-2H3&lt;br /&gt;
| StdInChIKey        = PBBGSZCBWVPOOL-UHFFFAOYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Hexestrol&amp;#039;&amp;#039;&amp;#039;, sold under the brand name &amp;#039;&amp;#039;&amp;#039;Synestrol&amp;#039;&amp;#039;&amp;#039; among others, is a [[nonsteroidal estrogen]] which was previously used for [[estrogen replacement therapy]] and in the treatment of certain [[hormone-dependent cancer]]s as well as [[gynecological disorder]]s but is mostly no longer marketed.&amp;lt;ref name=&amp;quot;Elks2014&amp;quot;&amp;gt;{{cite book| vauthors = Elks J |title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&amp;amp;pg=PA162|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=162–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;MortonHall2012&amp;quot;&amp;gt;{{cite book| vauthors = Morton IK, Hall JM |title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&amp;amp;pg=PA140|date=6 December 2012|publisher=Springer Science &amp;amp; Business Media|isbn=978-94-011-4439-1|pages=140–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Thomas1997&amp;quot;&amp;gt;{{cite book| vauthors = Thomas JA |title=Endocrine Toxicology, Second Edition|url=https://books.google.com/books?id=URc5JMoNirgC&amp;amp;pg=PA144|date=12 March 1997|publisher=CRC Press|isbn=978-1-4398-1048-4|pages=144–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Drugs.com&amp;quot;&amp;gt;{{Cite web|url=https://www.drugs.com/international/hexestrol.html|title = Estradiol: Uses, Dosage &amp;amp; Side Effects}}&amp;lt;/ref&amp;gt; It has also been used in the form of [[ester]]s such as [[hexestrol diacetate]] (brand name Sintestrol) and [[hexestrol dipropionate]] (brand name Hexanoestrol).&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;HorskyPresl2012&amp;quot; /&amp;gt; Hexestrol and its esters are taken [[oral administration|by mouth]], [[sublingual administration|held under the tongue]], or via [[intramuscular injection|injection into muscle]].&amp;lt;ref name=&amp;quot;HorskyPresl2012&amp;quot;&amp;gt;{{cite book| vauthors = Horsky J, Presl J |title=Ovarian Function and its Disorders: Diagnosis and Therapy|url=https://books.google.com/books?id=7IrpCAAAQBAJ&amp;amp;pg=PA310|date=6 December 2012|publisher=Springer Science &amp;amp; Business Media|isbn=978-94-009-8195-9|pages=83,85,145,310}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;ThomasKeenan2012&amp;quot;&amp;gt;{{cite book| vauthors = Thomas JA, Keenan EJ |title=Principles of Endocrine Pharmacology|url=https://books.google.com/books?id=mTagBQAAQBAJ&amp;amp;pg=PA153|date=6 December 2012|publisher=Springer Science &amp;amp; Business Media|isbn=978-1-4684-5036-1|pages=153–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;F.S.K.2012&amp;quot;&amp;gt;{{cite book | vauthors = Barar FS |title=Textbook of Pharmacology|url=https://books.google.com/books?id=ZDJlDwAAQBAJ&amp;amp;pg=PA348|year=2012|publisher=S. Chand Publishing|isbn=978-81-219-4080-1|pages=348–}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Medical uses==&lt;br /&gt;
Hexestrol has been used in [[estrogen replacement therapy]], for the treatment of [[breast cancer]] in women and [[prostate cancer]] in men, and for the treatment of certain [[gynecological disorder]]s.&amp;lt;ref name=&amp;quot;MortonHall2012&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Estrogen dosages for prostate cancer}}&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
===Pharmacodynamics===&lt;br /&gt;
Hexestrol has approximately 302% and 234% of the [[affinity (pharmacology)|affinity]] of [[estradiol (medication)|estradiol]] for the [[estrogen receptor]]s (ERs) [[ERα]] and [[ERβ]], respectively.&amp;lt;ref name=&amp;quot;pmid9048584&amp;quot;&amp;gt;{{cite journal | vauthors = Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA | title = Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta | journal = Endocrinology | volume = 138 | issue = 3 | pages = 863–870 | date = March 1997 | pmid = 9048584 | doi = 10.1210/endo.138.3.4979 | doi-access = free }}&amp;lt;/ref&amp;gt; The affinity of hexestrol for the ERs is said to be similar to or slightly higher than that of estradiol.&amp;lt;ref name=&amp;quot;pmid391285&amp;quot;&amp;gt;{{cite journal | vauthors = Leclercq G, Heuson JC | title = Physiological and pharmacological effects of estrogens in breast cancer | journal = Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | volume = 560 | issue = 4 | pages = 427–455 | date = December 1979 | pmid = 391285 | doi = 10.1016/0304-419x(79)90012-x }}&amp;lt;/ref&amp;gt; Along with [[diethylstilbestrol]], hexestrol has been said to be one of the most [[potency (pharmacology)|potent]] [[estrogen (medication)|estrogen]]s known.&amp;lt;ref name=&amp;quot;pmid21013428&amp;quot;&amp;gt;{{cite journal | vauthors = Solmssen UV | title = Synthetic estrogens and the relation between their structure and their activity | journal = Chemical Reviews | volume = 37 | issue = 3 | pages = 481–598 | date = December 1945 | pmid = 21013428 | doi = 10.1021/cr60118a004 }}&amp;lt;/ref&amp;gt; The total [[endometrium|endometrial]] [[cell proliferation|proliferation]] dose per cycle of different forms of hexestrol are 70 to 100&amp;amp;nbsp;mg for [[oral administration|oral]] hexestrol, 45&amp;amp;nbsp;mg for [[sublingual administration|sublingual]] [[hexestrol diacetate]], and 25&amp;amp;nbsp;mg for [[hexestrol dipropionate]] by [[intramuscular injection]].&amp;lt;ref name=&amp;quot;HorskyPresl2012&amp;quot; /&amp;gt; These doses are fairly similar to those of estradiol and its esters.&amp;lt;ref name=&amp;quot;HorskyPresl2012&amp;quot; /&amp;gt; Hexestrol induces [[mammary gland]] [[breast development|development]] in rodents similarly to other estrogens.&amp;lt;ref name=&amp;quot;CampbellDodds1939&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Nonsteroidal estrogens like diethylstilbestrol, which is closely related structurally to hexestrol, are known to have dramatically disproportionate estrogenic effects in the [[liver]] and on [[liver protein synthesis]].&amp;lt;ref name=&amp;quot;Kuhl2005&amp;quot;&amp;gt;{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | issue = Suppl 1 | pages = 3–63 | date = August 2005 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Parenteral potencies and durations of nonsteroidal estrogens}}&lt;br /&gt;
&lt;br /&gt;
===Pharmacokinetics===&lt;br /&gt;
[[File:Distribution of hexestrol radioactivity after a subcutaneous injection of tritiated hexestrol in oil solution in female goats.png|thumb|right|400px|[[Distribution (pharmacology)|Distribution]] of hexestrol [[radioactivity]] in [[blood]] and [[tissue (biology)|tissue]]s after a [[subcutaneous injection]] of a [[physiological]] dose of [[tritium]]-[[radiolabel|labeled]] hexestrol in [[oil solution]] in five juvenile female goats.&amp;lt;ref name=&amp;quot;pmid13828338&amp;quot;&amp;gt;{{cite journal | vauthors = Glascock RF, Hoekstra WG | title = Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep | journal = The Biochemical Journal | volume = 72 | issue = 4 | pages = 673–682 | date = August 1959 | pmid = 13828338 | pmc = 1196992 | doi = 10.1042/bj0720673 }}&amp;lt;/ref&amp;gt; Points are one animal each.&amp;lt;ref name=&amp;quot;pmid13828338&amp;quot; /&amp;gt; With the exception of [[skeletal muscle]], tissues with a radioactivity concentration of less than 15% of that of the [[endometrium]] are not shown.&amp;lt;ref name=&amp;quot;pmid13828338&amp;quot; /&amp;gt; Hexestrol is concentrated in [[target tissue]]s such as the [[uterus]] and [[vagina]] due to binding to [[estrogen receptor]]s.&amp;lt;ref name=&amp;quot;pmid4563437&amp;quot;&amp;gt;{{cite journal | vauthors = Jensen EV, DeSombre ER | title = Mechanism of action of the female sex hormones | journal = Annual Review of Biochemistry | volume = 41 | pages = 203–230 | date = 1972 | pmid = 4563437 | doi = 10.1146/annurev.bi.41.070172.001223 }}&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
The [[pharmacokinetics]] and [[distribution (pharmacology)|distribution]] of hexestrol have been studied with [[intravenous injection]] of [[aqueous solution]] in women and with [[subcutaneous injection]] of [[oil solution]] in female goats and sheep.&amp;lt;ref name=&amp;quot;pmid13893792&amp;quot;&amp;gt;{{cite journal | vauthors = Folca PJ, Glascock RF, Irvine WT | title = Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy | journal = Lancet | volume = 2 | issue = 7206 | pages = 796–798 | date = October 1961 | pmid = 13893792 | doi = 10.1016/s0140-6736(61)91088-1 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid13828338&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
{{See also|Stilbestrol#Stilbestrol derivatives|List of estrogen esters#Hexestrol esters}}&lt;br /&gt;
&lt;br /&gt;
Hexestrol, also known as dihydrodiethylstilbestrol, is a [[synthetic compound|synthetic]] [[nonsteroidal estrogen]] of the [[stilbestrol]] group related to [[diethylstilbestrol]].&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;MortonHall2012&amp;quot; /&amp;gt; [[Ester]]s of hexestrol include [[hexestrol diacetate]], [[hexestrol dicaprylate]], [[hexestrol diphosphate]], and [[hexestrol dipropionate]].&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
Hexestrol was first described by Campbell, Dodds, and Lawson in 1938.&amp;lt;ref name=&amp;quot;CampbellDodds1938&amp;quot;&amp;gt;{{cite journal| vauthors = Campbell NR, Dodds EC, Lawson W |title=Œstrogenic Activity of Anol; a Highly Active Phenol Isolated from the By-Products|journal=Nature|volume=142|issue=3608|year=1938|pages=1121|issn=0028-0836|doi=10.1038/1421121a0|bibcode=1938Natur.142.1121C|s2cid=4140616|doi-access=free}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;CampbellDodds1939&amp;quot;&amp;gt;{{cite journal| vauthors = Campbell NR, Dodds EC, Lawson W, Noble RL |title=Biological effects of the synthetic œstrogen hexœstrol|journal=The Lancet|volume=234|issue=6049|year=1939|pages=312–313|issn=0140-6736|doi=10.1016/S0140-6736(00)61997-9}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;MedChem1956&amp;quot;&amp;gt;{{cite book|title=Medicinal Chemistry|url=https://books.google.com/books?id=bpXVAAAAMAAJ|year=1956|publisher=John Wiley &amp;amp; Sons|page=40}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;CampbellDodds1940&amp;quot;&amp;gt;{{cite journal|vauthors=Campbell NR, Dodds EC, Lawson W|title=The nature of the oestrogenic substances produced during the demethylation of anethole|journal=Proceedings of the Royal Society of London. Series B, Biological Sciences|volume=128|issue=851|year=1940|pages=253–262|issn=2053-9193|doi=10.1098/rspb.1940.0009|bibcode=1940RSPSB.128..253C|doi-access=free}}&amp;lt;/ref&amp;gt; It was isolated from the [[demethylation]] products of [[anethole]].&amp;lt;ref name=&amp;quot;CampbellDodds1938&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;CampbellDodds1939&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;MedChem1956&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;CampbellDodds1940&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Society and culture==&lt;br /&gt;
&lt;br /&gt;
===Generic names===&lt;br /&gt;
&amp;#039;&amp;#039;Hexestrol&amp;#039;&amp;#039; is the [[generic term|generic name]] of the drug and its {{abbrlink|INN|International Nonproprietary Name}}.&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;MortonHall2012&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Brand names===&lt;br /&gt;
Hexestrol has been marketed under a variety of brand names including Synestrol, Synoestrol, Estrifar, and Estronal, among others.&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;MortonHall2012&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Availability===&lt;br /&gt;
Hexestrol has mostly been discontinued and remains available in only a handful of countries.&amp;lt;ref name=&amp;quot;Micromedex&amp;quot;&amp;gt;{{cite web | title = Micromdex | url = https://www.micromedexsolutions.com/ | publisher = Merative | access-date = 10 March 2023}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Drugs.com&amp;quot;/&amp;gt; Esters of hexestrol which have been marketed include [[hexestrol diacetate]], [[hexestrol dicaprylate]], [[hexestrol diphosphate]], and [[hexestrol dipropionate]].&amp;lt;ref name=&amp;quot;Elks2014&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Estrogens and antiestrogens}}&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Abandoned drugs]]&lt;br /&gt;
[[Category:4-Hydroxyphenyl compounds]]&lt;br /&gt;
[[Category:Stilbenoids]]&lt;br /&gt;
[[Category:Synthetic estrogens]]&lt;/div&gt;</summary>
		<author><name>bsd&gt;JWBE</name></author>
	</entry>
</feed>